Home > Insider Trading > Filing (0001209191-20-027953)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1123494	Harvard Bioscience Inc	HBIO	Laboratory Analytical Instruments (3826)	043306140

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1400121	W James Green	C/O Harvard Bioscience, Inc. 84 October Hill Road Holliston MA 01746	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-05-07	10,000	$2.53	1,512,445	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

This transaction was executed in multiple trades at prices ranging from $2.525 to $2.53, inclusive. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
Includes (a) deferred stock award of 35,100 restricted stock units which fully vest on May 23, 2020; (b) 202,875 restricted stock units that will fully vest on July 8, 2020; (c) 243,072 restricted stock units that will fully vest on July 8, 2021; (d) 313,770 restricted stock units that will vest in three equal installments on January 1, 2021, 2022 and 2023; (e) 418,360 restricted stock units with performance based vesting conditions tied to relative total shareholder return; and (f) 299,268 shares of common stock beneficially owned by the Reporting Person.